Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
7.39
+0.07 (0.96%)
Apr 30, 2026, 3:04 PM CST

SHE:000919 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,5171,7711,5481,4951,502
Short-Term Investments
393.03165.22337.45250-
Trading Asset Securities
939.31706.05233.8692.351.25
Cash & Short-Term Investments
2,8492,6422,1191,8371,503
Cash Growth
7.84%24.69%15.33%22.25%14.12%
Accounts Receivable
690.95686.73591.05467.22507.2
Other Receivables
13.798.168.7653.1216.85
Receivables
704.74694.89599.81520.34524.05
Inventory
233.14271.62290.91250.48245.48
Prepaid Expenses
--0.151.16-
Other Current Assets
10.529.379.6323.7916.29
Total Current Assets
3,7983,6183,0202,6332,289
Property, Plant & Equipment
1,4571,5011,5411,3031,297
Long-Term Investments
211.37431.07369.32265.01638.97
Goodwill
44.3762.42148.7227.3318.05
Other Intangible Assets
322.93325.67341.67258.44140.2
Long-Term Deferred Tax Assets
12.6112.4916.6128.5419.62
Long-Term Deferred Charges
120.5583.3413.9418.2617.85
Other Long-Term Assets
40.3154.494210.726.96
Total Assets
6,0076,0895,4934,5444,448
Accounts Payable
554.97595.31546.69454.04479.36
Accrued Expenses
222.28212.46224.73219.95207.27
Short-Term Debt
---1.4815.01
Current Portion of Leases
8.744.233.081.531.06
Current Income Taxes Payable
32.3735.5337.9748.3843.09
Current Unearned Revenue
19.5735.617.6522.1426.9
Other Current Liabilities
138.03143.9182.53117.983.25
Total Current Liabilities
975.951,0271,013865.42855.95
Long-Term Debt
150.1150.12---
Long-Term Leases
32.9834.8538.62.290.59
Long-Term Unearned Revenue
0.6810.470.630.79
Long-Term Deferred Tax Liabilities
25.0127.2828.7248.9855.77
Total Liabilities
1,1851,2401,080917.32913.1
Common Stock
621.92623.71511.14510.4504
Additional Paid-In Capital
1,0881,098651.74478.34462.06
Retained Earnings
2,0652,0732,0952,0251,958
Treasury Stock
--6.77-26.99-23.62-
Comprehensive Income & Other
2.663.093.424.173.29
Total Common Equity
3,7783,7913,2342,9942,928
Minority Interest
1,0441,0571,178632.88606.84
Shareholders' Equity
4,8224,8494,4123,6273,535
Total Liabilities & Equity
6,0076,0895,4934,5444,448
Total Debt
191.82189.2141.675.316.66
Net Cash (Debt)
2,6582,4532,0771,8321,486
Net Cash Growth
8.34%18.08%13.39%23.26%12.85%
Net Cash Per Share
4.274.144.123.642.95
Filing Date Shares Outstanding
621.92623.71629.06488.88510.4
Total Common Shares Outstanding
621.92623.71511.14488.88504
Working Capital
2,8222,5912,0071,7681,433
Book Value Per Share
6.076.086.336.125.81
Tangible Book Value
3,4103,4032,7442,7082,769
Tangible Book Value Per Share
5.485.465.375.545.50
Buildings
1,5101,4951,5071,2941,274
Machinery
1,4981,4161,3491,1141,074
Construction In Progress
48.1671.7884.237.8428.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.